http://rdf.ncbi.nlm.nih.gov/pubchem/patent/NZ-532988-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_afc5d8c9ee6673323cee3e2d19bc5146 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1816 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-06 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-06 |
| filingDate | 2002-11-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ea8a0091e44426aaa48865b19d8164f9 |
| publicationDate | 2008-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | NZ-532988-A |
| titleOfInvention | Erythropoietin dosing regimen for treating anemia |
| abstract | Disclosed is the use of erythropoietin in the preparation of a medicament for erythropoietin treatment in a patient in need thereof, wherein the medicament is formulated for administration according to a dosage regimen by: a) dosing a patient by subcutaneous injection once every week with a therapeutically effective amount of erythropoietin until a hemoglobin increase of about 2g/dL is achieved; and b) dosing said patient by subcutaneous injection once every two weeks with an amount of erythropoietin that is greater than the amount dosed in step (a). |
| priorityDate | 2001-11-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 53.